{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T17:03:48Z","timestamp":1756573428938,"version":"3.28.0"},"reference-count":69,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>When progressive and severe, myasthenia gravis and Guillain\u2013Barr\u00e9 syndrome may have the potential for fatal and unfavorable clinical outcomes. Regardless of important differences in their clinical course, the development of weakness of oropharyngeal muscles and respiratory failure with requirement of mechanical ventilation is the main driver of poor prognosis in both conditions. The need for prolonged mechanical ventilation is particularly relevant because it immobilizes the patient and care becomes extraordinarily complex due to daily risks of systemic complications. Additionally, patients with myasthenia gravis often require long-term immunosuppressive treatments with associated toxicity and infectious risks. Unlike myasthenia gravis, the recovery period is prolonged in Guillain\u2013Barr\u00e9 syndrome, but often favorable, even in the more severely affected patients. Outcome, for a large part, is determined by expert neurocritical care.<\/jats:p>","DOI":"10.1055\/s-0044-1785509","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T22:41:25Z","timestamp":1712011285000},"page":"263-270","source":"Crossref","is-referenced-by-count":1,"title":["Improving Outcome in Severe Myasthenia Gravis and Guillain\u2013Barr\u00e9 Syndrome"],"prefix":"10.1055","volume":"44","author":[{"given":"Maximiliano A.","family":"Hawkes","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurocritical Care Services, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eelco F. M.","family":"Wijdicks","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurocritical Care Services, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"N E Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"N Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"ref3","first-page":"1324","article-title":"Acute neuromuscular respiratory failure","volume":"21","author":"A A Rabinstein","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"issue":"26","key":"ref4","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"N E Gilhus","year":"2016","journal-title":"N Engl J Med"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: a systematic literature review","volume":"34","author":"A McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"key":"ref6","first-page":"100063","article-title":"Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study","volume":"5","author":"J Chen","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s12967-021-03185-7","article-title":"Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis","volume":"19","author":"N Salari","year":"2021","journal-title":"J Transl Med"},{"issue":"09","key":"ref8","doi-asserted-by":"crossref","first-page":"e0274161","DOI":"10.1371\/journal.pone.0274161","article-title":"Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018","volume":"17","author":"H Yoshikawa","year":"2022","journal-title":"PLoS One"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1941875210382918","article-title":"Myasthenic crisis","volume":"1","author":"L C Wendell","year":"2011","journal-title":"Neurohospitalist"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00003246-199707000-00027","article-title":"Therapy of myasthenic crisis","volume":"25","author":"J Berrouschot","year":"1997","journal-title":"Crit Care Med"},{"issue":"18","key":"ref11","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","article-title":"Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals","volume":"72","author":"A Alshekhlee","year":"2009","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"895007","DOI":"10.3389\/fimmu.2022.895007","article-title":"Development and validation of a nomogram for predicting generalization in patients with ocular myasthenia gravis","volume":"13","author":"Z Ruan","year":"2022","journal-title":"Front Immunol"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"D Grob","year":"2008","journal-title":"Muscle Nerve"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1385\/NCC:3:3:213","article-title":"Risk of extubation failure in patients with myasthenic crisis","volume":"3","author":"A A Rabinstein","year":"2005","journal-title":"Neurocrit Care"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","article-title":"Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"C E Thomas","year":"1997","journal-title":"Neurology"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1212\/WNL.0000000000008688","article-title":"Myasthenic crisis demanding mechanical ventilation: a multicenter analysis of 250 cases","volume":"94","author":"B Neumann","year":"2020","journal-title":"Neurology"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/ane.13576","article-title":"Myasthenia gravis-treatment and severity in nationwide cohort","volume":"145","author":"E Sobieszczuk","year":"2022","journal-title":"Acta Neurol Scand"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ene.14820","article-title":"Clinical characteristics and outcomes of thymoma-associated myasthenia gravis","volume":"28","author":"R \u00c1lvarez-Velasco","year":"2021","journal-title":"Eur J Neurol"},{"issue":"05","key":"ref19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mus.26132","article-title":"Survival and mortality of adult-onset myasthenia gravis in the population of Belgrade, Serbia","volume":"58","author":"I Basta","year":"2018","journal-title":"Muscle Nerve"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12883-019-1384-5","article-title":"Myasthenic crisis treated in a Chinese neurological intensive care unit: clinical features, mortality, outcomes, and predictors of survival","volume":"19","author":"F Liu","year":"2019","journal-title":"BMC Neurol"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1212\/WNL.0000000000008903","article-title":"Clinical and therapeutic features of myasthenia gravis in adults based on age at onset","volume":"94","author":"E Cort\u00e9s-Vicente","year":"2020","journal-title":"Neurology"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mus.24697","article-title":"Mortality in myasthenia gravis: a nationwide population-based follow-up study in Denmark","volume":"53","author":"J S Hansen","year":"2016","journal-title":"Muscle Nerve"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s42466-020-00091-z","article-title":"Outcome measures and treatment effectiveness in late onset myasthenia gravis","volume":"2","author":"F Pasqualin","year":"2020","journal-title":"Neurol Res Pract"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1111\/ene.14951","article-title":"Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival","volume":"28","author":"M Jakub\u00edkov\u00e1","year":"2021","journal-title":"Eur J Neurol"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s10072-021-05823-w","article-title":"Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review","volume":"43","author":"C L Rodrigues","year":"2022","journal-title":"Neurol Sci"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/ane.13440","article-title":"Myasthenia gravis and COVID-19: a case series and comparison with literature","volume":"144","author":"Z Saied","year":"2021","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"J F Howard Jr","year":"2017","journal-title":"Lancet Neurol"},{"issue":"23","key":"ref28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/WNL.0000000000007605","article-title":"Efgartigimod: a novel antibody depletion therapy in myasthenia gravis","volume":"92","author":"A C Guidon","year":"2019","journal-title":"Neurology"},{"issue":"05","key":"ref29","first-page":"a2100066","article-title":"Terminal complement inhibitor ravulizumab in generalized myasthenia gravis","volume":"1","author":"T Vu","year":"2022","journal-title":"NEJM Evid"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/08916930903518107","article-title":"Immunosuppressive therapies in myasthenia gravis","volume":"43","author":"D B Sanders","year":"2010","journal-title":"Autoimmunity"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2022.2887","article-title":"Efficacy and safety of rituximab for new-onset generalized myasthenia gravis: the RINOMAX randomized clinical trial","volume":"79","author":"F Piehl","year":"2022","journal-title":"JAMA Neurol"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"G I Wolfe","year":"2016","journal-title":"N Engl J Med"},{"issue":"09","key":"ref33","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/14737175.2019.1600404","article-title":"An update on thymectomy in myasthenia gravis","volume":"19","author":"A Evoli","year":"2019","journal-title":"Expert Rev Neurother"},{"issue":"08","key":"ref34","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/ene.15362","article-title":"Short-term and sustained clinical response following thymectomy in patients with myasthenia gravis","volume":"29","author":"J Rath","year":"2022","journal-title":"Eur J Neurol"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"S E Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome","volume":"141","author":"A Y Doets","year":"2018","journal-title":"Brain"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"J J Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12974-021-02319-4","article-title":"Global, regional, and national burden of Guillain-Barr\u00e9 syndrome and its underlying causes from 1990 to 2019","volume":"18","author":"N L Bragazzi","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1111\/ene.15497","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19: a 1-year observational multicenter study","volume":"29","author":"M Filosto","year":"2022","journal-title":"Eur J Neurol"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000527726","article-title":"Decreased incidence of Guillain-Barr\u00e9 syndrome during the COVID-19 pandemic: a retrospective population-based study","volume":"57","author":"B Hafsteinsd\u00f3ttir","year":"2023","journal-title":"Neuroepidemiology"},{"issue":"20","key":"ref41","doi-asserted-by":"crossref","first-page":"e2035","DOI":"10.1212\/WNL.0000000000207900","article-title":"Association between Guillain-Barr\u00e9 syndrome and COVID-19 infection and vaccination: a population-based nested case-control study","volume":"101","author":"H Bishara","year":"2023","journal-title":"Neurology"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-020-00742-z","article-title":"Early mechanical ventilation in patients with Guillain-Barr\u00e9 syndrome at high risk of respiratory failure: a randomized trial","volume":"10","author":"M A Melone","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"09","key":"ref43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/jnnp-2018-317968","article-title":"Clinical outcome of Guillain-Barr\u00e9 syndrome after prolonged mechanical ventilation","volume":"89","author":"B van den Berg","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12028-019-00781-w","article-title":"Dysautonomia in Guillain-Barr\u00e9 syndrome: prevalence, clinical spectrum, and outcomes","volume":"32","author":"T Chakraborty","year":"2020","journal-title":"Neurocrit Care"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barr\u00e9 syndrome","volume":"92","author":"E FM Wijdicks","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"07","key":"ref46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","article-title":"Outcome and its predictors in Guillain-Barre syndrome","volume":"83","author":"Y A Rajabally","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"18","key":"ref47","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182904fcc","article-title":"Mortality in Guillain-Barre syndrome","volume":"80","author":"B van den Berg","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/WNL.0b013e3182104407","article-title":"Early recognition of poor prognosis in Guillain-Barre syndrome","volume":"76","author":"C Walgaard","year":"2011","journal-title":"Neurology"},{"issue":"21","key":"ref49","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome","volume":"333","author":"J H Rees","year":"1995","journal-title":"N Engl J Med"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.410230406","article-title":"Plasmapheresis and Guillain-Barr\u00e9 syndrome: analysis of prognostic factors and the effect of plasmapheresis","volume":"23","author":"G M McKhann","year":"1988","journal-title":"Ann Neurol"},{"issue":"18","key":"ref51","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1212\/01.wnl.0000310983.38724.d4","article-title":"Guillain-Barr\u00e9 syndrome: incidence and mortality rates in US hospitals","volume":"70","author":"A Alshekhlee","year":"2008","journal-title":"Neurology"},{"issue":"06","key":"ref52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","article-title":"Prediction of respiratory insufficiency in Guillain-Barr\u00e9 syndrome","volume":"67","author":"C Walgaard","year":"2010","journal-title":"Ann Neurol"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/jns.12234","article-title":"Markers for Guillain-Barr\u00e9 syndrome with poor prognosis: a multi-center study","volume":"22","author":"Y Yamagishi","year":"2017","journal-title":"J Peripher Nerv Syst"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12028-021-01218-z","article-title":"Predicting mechanical ventilation using the EGRIS in Guillain-Barr\u00e9 syndrome in a Latin American country","volume":"35","author":"M Malaga","year":"2021","journal-title":"Neurocrit Care"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.26312","article-title":"International validation of the erasmus Guillain-Barr\u00e9 syndrome respiratory insufficiency score","volume":"91","author":"A Y Doets","year":"2022","journal-title":"Ann Neurol"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/cc10043","article-title":"A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain-Barr\u00e9 syndrome","volume":"15","author":"F Fourrier","year":"2011","journal-title":"Crit Care"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-016-0311-5","article-title":"Tracheostomy or not: prediction of prolonged mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"26","author":"C Walgaard","year":"2017","journal-title":"Neurocrit Care"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12028-020-00965-9","article-title":"Effect of early tracheostomy on mortality of mechanically ventilated patients with Guillain-Barr\u00e9 syndrome: a nationwide observational study","volume":"33","author":"N Yonezawa","year":"2020","journal-title":"Neurocrit Care"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000013139","article-title":"Predicting outcome in Guillain-Barr\u00e9 syndrome: international validation of the modified erasmus GBS outcome score","volume":"98","author":"A Y Doets","year":"2022","journal-title":"Neurology"},{"issue":"08","key":"ref60","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/acn3.51627","article-title":"Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh","volume":"9","author":"N Papri","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"09","key":"ref61","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1111\/ene.15428","article-title":"Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies","volume":"29","author":"I Kmezic","year":"2022","journal-title":"Eur J Neurol"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-020-01737-0","article-title":"Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barr\u00e9 syndrome","volume":"17","author":"P Altmann","year":"2020","journal-title":"J Neuroinflammation"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323899","article-title":"Serum neurofilament light chain predicts long-term prognosis in Guillain-Barr\u00e9 syndrome patients","author":"L Mart\u00edn-Aguilar","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"972367","DOI":"10.3389\/fneur.2022.972367","article-title":"Cerebrospinal fluid neurofilament light chain predicts short-term prognosis in pediatric Guillain-Barr\u00e9 syndrome","volume":"13","author":"M Jin","year":"2022","journal-title":"Front Neurol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2016.03.008","article-title":"Recurrent Guillain-Barr\u00e9 syndrome, Miller Fisher syndrome and Bickerstaff brainstem encephalitis","volume":"364","author":"J Ishii","year":"2016","journal-title":"J Neurol Sci"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2016.02.053","article-title":"Demyelinating Guillain-Barr\u00e9 syndrome recurs more frequently than axonal subtypes","volume":"365","author":"F Notturno","year":"2016","journal-title":"J Neurol Sci"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.2008.156463","article-title":"Recurrent Guillain-Barr\u00e9 syndrome","volume":"80","author":"K Kuitwaard","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"02","key":"ref68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3988\/jcn.2007.3.2.105","article-title":"Fulminant guillain-barr\u00e9 syndrome mimicking cerebral death following acute viral hepatitis a","volume":"3","author":"B H Kang","year":"2007","journal-title":"J Clin Neurol"},{"issue":"8439","key":"ref69","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(85)92875-2","article-title":"Prognosis in Guillain-Barr\u00e9 syndrome","volume":"1","author":"J B Winer","year":"1985","journal-title":"Lancet"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1785509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:46:14Z","timestamp":1730817974000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1785509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":69,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2024,6,19]]},"published-print":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1785509","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"type":"print","value":"0271-8235"},{"type":"electronic","value":"1098-9021"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}